Humacyte, Inc. (NASDAQ:HUMA) Q2 2022 Earnings Conference Call August 12, 2022 8:00 AM ET
Company Participants
Lauren Marek - LifeSci Advisors, IR
Dr. Laura Niklason - President and CEO
Dale Sander - Chief Financial Officer and Chief Corporate Development Officer
Dr. Heather Prichard - Chief Operating Officer
Conference Call Participants
Brooks O'Neil - Lake Street Capital
Ryan Zimmerman - BTIG
Matthew O'Brien - Piper Sandler
Suraj Kalia - Oppenheimer
Josh Jennings - Cowen
Bruce Jackson - The Benchmark Company
Operator
Good morning, ladies and gentlemen. And welcome to the Humacyte Second Quarter 2022 Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference call is being recorded.
I will now turn the call over to Lauren Marek with LifeSci Advisors. Please go ahead.
Lauren Marek
Thank you, Operator. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws.
These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Any additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC.
The forward-looking statements made during this call speak only as of the date hereof and the company undertakes no obligation to update or revise the forward-looking statements except as required by law.
Information presented on this call is contained in the press release we issued this morning and in our Form 10-Q, which will be filed today and maybe accessed from the Investors page of the Humacyte website.
Joining me on today’s call from Humacyte are Dr. Laura Niklason, President and Chief Executive Officer; Dale Sander, Chief Financial Officer and Chief Corporate Development Officer; and Dr. Heather Prichard, Chief Operating Officer.
Dr. Niklason will provide a summary of the company’s progress during the quarter and recent weeks and Dale will review the company’s financial results. Following their prepared remarks, the management team will be available for your questions.
I will now turn the call over to Dr. Niklason.
Dr. Laura Niklason
Thank you, Lauren. Good morning, everyone, and thank you for joining us for our second quarter 2022 financial results and business update call. During this call, I’ll review our recent highlights and progress of our key programs, before turning the call over to Dale for a review of our financial results. Then we will be happy to open up the call for your questions.